2,6-Dichlorobenzoyl chloride → HCID 57923875, compound
Reaction equation
[CH2:1]([S:4]([N:7]1[CH2:12][CH2:11][C:10]([C@@H:19]([NH2:21])[CH3:20])([C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][N:14]=2)[CH2:9][CH2:8]1)(=[O:6])=[O:5])[CH2:2][CH3:3].CCN(C(C)C)C(C)C.[Cl:31][C:32]1[CH:40]=[CH:39][CH:38]=[C:37]([Cl:41])[C:33]=1[C:34](Cl)=[O:35]>CN(C=O)C>[Cl:31][C:32]1[CH:40]=[CH:39][CH:38]=[C:37]([Cl:41])[C:33]=1[C:34]([NH:21][C@H:19]([C:10]1([C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][N:14]=2)[CH2:9][CH2:8][N:7]([S:4]([CH2:1][CH2:2][CH3:3])(=[O:5])=[O:6])[CH2:12][CH2:11]1)[CH3:20])=[O:35]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of {(1S)-1-[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]ethyl}amine (80 mg, 0.26 mmol) in DMF (0.7 mL) was treated with i-Pr2NEt (0.2 mL, 1.15 mmol) and 2,6-dichloro-benzoyl chloride (0.15 mL, 0.8 mmol) and stirred at room temperature for 30 min. The reaction mixture was purified directly by reverse phase HPLC to afford the desired product.
Workup
- customThe reaction mixture was purified directly by reverse phase HPLC
Sources & evidence
- ORD record
- ord-d3118afb3f68432f9ee26281e2161701
- Source dataset
- uspto-grants-2010_11
- Patent number
- US07834031B2
Reaction notes
Loading…